These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 21942498)

  • 1. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
    Luo YL; Shiao YS; Huang YF
    ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
    Shiao YS; Chiu HH; Wu PH; Huang YF
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
    He X; Hai L; Su J; Wang K; Wu X
    Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.
    Alexander CM; Dabrowiak JC; Maye MM
    Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
    Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
    ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-capped nanoparticles designed for doxorubicin drug delivery.
    Alexander CM; Maye MM; Dabrowiak JC
    Chem Commun (Camb); 2011 Mar; 47(12):3418-20. PubMed ID: 21286626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
    Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
    Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment and fluorescence enhancement of adenosine using aptamer-gold nanoparticles, PDGF aptamer, and Oligreen.
    Chen SJ; Huang CC; Chang HT
    Talanta; 2010 Apr; 81(1-2):493-8. PubMed ID: 20188952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment.
    Sathiyaseelan A; Saravanakumar K; Mariadoss AVA; Wang MH
    Carbohydr Polym; 2021 Jun; 262():117907. PubMed ID: 33838795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
    Zhang X; Chibli H; Mielke R; Nadeau J
    Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor mRNA-dependent gold nanoparticle-molecular beacon carrier for controlled drug release and intracellular imaging.
    Qiao G; Zhuo L; Gao Y; Yu L; Li N; Tang B
    Chem Commun (Camb); 2011 Jul; 47(26):7458-60. PubMed ID: 21589964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
    Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
    Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
    Li R; Wu R; Zhao L; Wu M; Yang L; Zou H
    ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.